These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1368788)

  • 21. Current and future impact of green chemistry on the pharmaceutical industry.
    Fortunak JM
    Future Med Chem; 2009 Jul; 1(4):571-5. PubMed ID: 21426025
    [No Abstract]   [Full Text] [Related]  

  • 22. Fragmentary solutions. Astex therapeutics puts the pieces together.
    Wolfson W
    Chem Biol; 2006 Aug; 13(8):799-801. PubMed ID: 16931326
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug industry looks to the lab instead of rainforest and reef.
    Service RF
    Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
    [No Abstract]   [Full Text] [Related]  

  • 24. Greener pharmaceuticals.
    Clark JH; Breeden SW; Summerton L
    Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
    [No Abstract]   [Full Text] [Related]  

  • 25. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
    Calcaterra A; D'Acquarica I
    J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race for molecular summits.
    Service RF
    Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
    [No Abstract]   [Full Text] [Related]  

  • 27. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis.
    GawroĊ„ski J
    Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.
    Peake DA; Ackermann BL
    J Am Soc Mass Spectrom; 2005 Apr; 16(4):599-605. PubMed ID: 15871168
    [No Abstract]   [Full Text] [Related]  

  • 29. The dilemma of process development.
    Shultis K
    Drug Discov Today; 2002 Aug; 7(16):850-3. PubMed ID: 12546947
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthetic approaches to the 2007 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Li J
    Mini Rev Med Chem; 2008 Dec; 8(14):1526-48. PubMed ID: 19075810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
    Rantanen J; Khinast J
    Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
    [No Abstract]   [Full Text] [Related]  

  • 33. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 34. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical forecasting: throwing darts?
    Cha M; Rifai B; Sarraf P
    Nat Rev Drug Discov; 2013 Oct; 12(10):737-8. PubMed ID: 24080692
    [No Abstract]   [Full Text] [Related]  

  • 36. Organic synthesis remains relevant in drug discovery.
    Mehrotra MM
    Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370
    [No Abstract]   [Full Text] [Related]  

  • 37. Advances and Progress in Drug Design - SMi's ninth annual meeting.
    Welchman R
    IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chirality and its importance in drug development: a synthetic chemist's perspective.
    Roberts SM
    Biochem Soc Trans; 1991 Apr; 19(2):446-53. PubMed ID: 1889627
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective use of preparative chiral HPLC in a preclinical drug synthesis.
    Nelson TD; Welch CJ; Rosen JD; Smitrovich JH; Huffman MA; McNamara JM; Mathre DJ
    Chirality; 2004 Nov; 16(9):609-13. PubMed ID: 15390084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.